Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 12851-12900 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04720326
Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients
PHASE4Active, not recruiting
268 participants
Started: Dec 23, 2020 · Completed: Oct 31, 2026
1 condition3 sponsors15 locations
NCT04961632
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
PHASE1Active, not recruiting
75 participants
Started: Dec 23, 2020 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT04842591
Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation
N/AActive, not recruiting
60 participants
Started: Dec 23, 2020 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT04828629
Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity
N/AActive, not recruiting
100 participants
Started: Dec 23, 2020 · Completed: Jan 1, 2025
2 conditions1 sponsor1 location
NCT04547504
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %
PHASE3Active, not recruiting
349 participants
Started: Dec 22, 2020 · Completed: Dec 22, 2025
1 condition2 sponsors29 locations
NCT05035667
Patient Considerations of Social Media Account Management After Death
N/AActive, not recruiting
117 participants
Started: Dec 22, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04794010
A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer
N/AActive, not recruiting
825 participants
Started: Dec 22, 2020 · Completed: Dec 22, 2027
1 condition1 sponsor1 location
NCT04260867
Essential Oils for Electrocautery
NAActive, not recruiting
111 participants
Started: Dec 22, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04564911
GLucose Monitoring Programme SingaporE, Phase 2 (GLiMPSE2)
NAActive, not recruiting
206 participants
Started: Dec 22, 2020 · Completed: Dec 30, 2023
2 conditions5 sponsors3 locations
NCT04165083
KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B)
PHASE2Active, not recruiting
120 participants
Started: Dec 22, 2020 · Completed: Oct 31, 2025
1 condition1 sponsor39 locations
NCT04707248
A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors
PHASE1Active, not recruiting
179 participants
Started: Dec 22, 2020 · Completed: Jun 30, 2026
2 conditions2 sponsors13 locations
NCT04526730
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
PHASE2Active, not recruiting
17 participants
Started: Dec 22, 2020 · Completed: Jun 15, 2028
1 condition2 sponsors1 location
NCT04785534
Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis
NAActive, not recruiting
1,000 participants
Started: Dec 22, 2020 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT04898231
MIS-C Comparative Effectiveness Study
PHASE2/PHASE3Active, not recruiting
73 participants
Started: Dec 22, 2020 · Completed: Jul 31, 2025
1 condition2 sponsors2 locations
NCT04641143
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
PHASE3Active, not recruiting
700 participants
Started: Dec 22, 2020 · Completed: Nov 30, 2025
1 condition1 sponsor73 locations
NCT04656652
Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)
PHASE3Active, not recruiting
605 participants
Started: Dec 21, 2020 · Completed: Jan 31, 2026
1 condition2 sponsors209 locations
NCT04665856
Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
PHASE3Active, not recruiting
123 participants
Started: Dec 21, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor16 locations
NCT04625270
A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation
PHASE2Active, not recruiting
225 participants
Started: Dec 21, 2020 · Completed: Dec 31, 2026
2 conditions3 sponsors47 locations
NCT04250051
Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia
PHASE1Active, not recruiting
2 participants
Started: Dec 21, 2020 · Completed: Dec 1, 2028
5 conditions2 sponsors1 location
NCT04305795
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
23 participants
Started: Dec 21, 2020 · Completed: Jun 30, 2027
4 conditions1 sponsor7 locations
NCT04607421
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
PHASE3Active, not recruiting
831 participants
Started: Dec 21, 2020 · Completed: Dec 28, 2027
1 condition4 sponsors268 locations
NCT04572230
International Post Market Surveillance Study of Intracranial Aneurysms Treated With an Endovascular Approach
N/AActive, not recruiting
405 participants
Started: Dec 21, 2020 · Completed: Aug 31, 2025
1 condition1 sponsor32 locations
NCT04565015
Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
PHASE3Active, not recruiting
24 participants
Started: Dec 21, 2020 · Completed: Nov 30, 2026
1 condition2 sponsors8 locations
NCT04624737
Intelligent Evaluation of Diabetic Retinopathy
N/AActive, not recruiting
5,000 participants
Started: Dec 21, 2020 · Completed: Feb 21, 2025
1 condition1 sponsor14 locations
NCT04602533
Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)
PHASE2Active, not recruiting
105 participants
Started: Dec 21, 2020 · Completed: Dec 31, 2026
1 condition2 sponsors16 locations
NCT04663308
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)
PHASE2Active, not recruiting
182 participants
Started: Dec 18, 2020 · Completed: Apr 30, 2027
1 condition1 sponsor103 locations
NCT04666740
A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy
PHASE2Active, not recruiting
63 participants
Started: Dec 18, 2020 · Completed: Jan 31, 2026
2 conditions2 sponsors7 locations
NCT04171492
Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules
N/AActive, not recruiting
2,000 participants
Started: Dec 18, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor25 locations
NCT04641442
Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
PHASE2Active, not recruiting
17 participants
Started: Dec 18, 2020 · Completed: Sep 11, 2027
1 condition1 sponsor21 locations
NCT04584255
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
PHASE2Active, not recruiting
62 participants
Started: Dec 18, 2020 · Completed: Jul 17, 2029
8 conditions4 sponsors8 locations
NCT04640623
A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy
PHASE2Active, not recruiting
220 participants
Started: Dec 18, 2020 · Completed: Jul 2, 2027
1 condition1 sponsor144 locations
NCT05049044
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)
N/AActive, not recruiting
413 participants
Started: Dec 18, 2020 · Completed: Jun 30, 2027
1 condition2 sponsors34 locations
NCT03721497
Testosterone in Bariatric Patients
PHASE4Active, not recruiting
64 participants
Started: Dec 17, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04069624
Kentucky Women's Justice Community Opioid Innovation Network
NAActive, not recruiting
900 participants
Started: Dec 17, 2020 · Completed: Apr 30, 2026
1 condition2 sponsors9 locations
NCT04430179
Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
PHASE2Active, not recruiting
30 participants
Started: Dec 17, 2020 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06099548
Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients
NAActive, not recruiting
20 participants
Started: Dec 17, 2020 · Completed: Jun 1, 2026
1 condition1 sponsor2 locations
NCT04447027
Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
PHASE1Active, not recruiting
26 participants
Started: Dec 17, 2020 · Completed: May 15, 2026
4 conditions1 sponsor1 location
NCT04556773
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
PHASE1Active, not recruiting
138 participants
Started: Dec 17, 2020 · Completed: Dec 4, 2025
1 condition3 sponsors37 locations
NCT04416178
Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
N/AActive, not recruiting
300 participants
Started: Dec 17, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04380350
Trenza Embolization Device for Intrasaccular Aneurysm Treatment
N/AActive, not recruiting
150 participants
Started: Dec 17, 2020 · Completed: Mar 30, 2027
2 conditions1 sponsor18 locations
NCT04733443
The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis
NAActive, not recruiting
310 participants
Started: Dec 17, 2020 · Completed: Feb 18, 2025
1 condition1 sponsor1 location
NCT04098237
Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency
PHASE2Active, not recruiting
36 participants
Started: Dec 17, 2020 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT05653141
Post-stroke Cognitive Impairment
N/AActive, not recruiting
335 participants
Started: Dec 17, 2020 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT04916730
Effect of Time-restricted Eating on Catecholamine-sensitivity of Adipose Tissue in Obese Adults
NAActive, not recruiting
61 participants
Started: Dec 17, 2020 · Completed: Jan 1, 2026
1 condition2 sponsors1 location
NCT04300920
Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial
PHASE3Active, not recruiting
202 participants
Started: Dec 17, 2020 · Completed: Feb 27, 2026
1 condition7 sponsors25 locations
NCT04616807
An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders
N/AActive, not recruiting
53 participants
Started: Dec 17, 2020 · Completed: Jan 24, 2026
1 condition1 sponsor6 locations
NCT04626518
Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)
PHASE1/PHASE2Active, not recruiting
370 participants
Started: Dec 17, 2020 · Completed: May 31, 2026
1 condition1 sponsor51 locations
NCT04590235
A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
PHASE1Active, not recruiting
32 participants
Started: Dec 16, 2020 · Completed: Aug 31, 2026
2 conditions2 sponsors2 locations
NCT04490915
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
PHASE3Active, not recruiting
182 participants
Started: Dec 16, 2020 · Completed: Aug 31, 2027
1 condition1 sponsor70 locations
NCT04351555
A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
PHASE3Active, not recruiting
358 participants
Started: Dec 16, 2020 · Completed: Jun 13, 2029
1 condition1 sponsor158 locations